Boxer Capital, Llc Buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, Sells Seagen Inc, Amarin Corp PLC, Therapeutics Acquisition Corp

• New Purchases: TYRA, TNGX, BPMC, FULC, TPTX, IOVA, NUVL, PRTA, PNT, ELEV, ERAS, LABD, SRZN,
• Added Positions: KNTE, CNTA,
• Reduced Positions: SLDB, GOSS,
• Sold Out: SGEN, AMRN, RACA, KDMN, AGEN, BMRN, MREO, CERE, CBAY, PSTX, ESPR, IMVT, MTNB, QURE, MIRM, AGLE, CHFW.U, BOLT, BOLT, ZGNX,

For the details of BOXER CAPITAL, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/boxer+capital%2C+llc/current-portfolio/portfolio

1. Mirati Therapeutics Inc (MRTX) - 2,000,000 shares, 12.36% of the total portfolio.
2. BeiGene Ltd (BGNE) - 764,188 shares, 9.69% of the total portfolio.
3. SpringWorks Therapeutics Inc (SWTX) - 2,075,905 shares, 4.60% of the total portfolio.
4. ITeos Therapeutics Inc (ITOS) - 4,345,016 shares, 4.10% of the total portfolio.
5. Tyra Biosciences Inc (TYRA) - 6,323,359 shares, 3.88% of the total portfolio. New Position

Boxer Capital, Llc initiated holding in Tyra Biosciences Inc. The purchase prices were between $16.91 and $26, with an estimated average price of $19.11. The stock is now traded at around $20.210000. The impact to a portfolio due to this purchase was 3.88%. The holding were 6,323,359 shares as of 2021-09-30.

Boxer Capital, Llc initiated holding in Tango Therapeutics Inc. The purchase prices were between $9.56 and $17.3, with an estimated average price of $13.13. The stock is now traded at around $10.410000. The impact to a portfolio due to this purchase was 3.1%. The holding were 6,871,642 shares as of 2021-09-30.

Boxer Capital, Llc initiated holding in Blueprint Medicines Corp. The purchase prices were between $80.98 and $109.47, with an estimated average price of $93.09. The stock is now traded at around $104.290000. The impact to a portfolio due to this purchase was 1.53%. The holding were 425,000 shares as of 2021-09-30.

Boxer Capital, Llc initiated holding in Fulcrum Therapeutics Inc. The purchase prices were between $7.28 and $30.97, with an estimated average price of $18.95. The stock is now traded at around $15.210000. The impact to a portfolio due to this purchase was 1.23%. The holding were 1,250,000 shares as of 2021-09-30.

Boxer Capital, Llc initiated holding in Turning Point Therapeutics Inc. The purchase prices were between $61 and $81.99, with an estimated average price of $71.44. The stock is now traded at around $41.680000. The impact to a portfolio due to this purchase was 1.22%. The holding were 525,000 shares as of 2021-09-30.

Boxer Capital, Llc initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $18.710000. The impact to a portfolio due to this purchase was 0.95%. The holding were 1,100,000 shares as of 2021-09-30.

Boxer Capital, Llc added to a holding in Kinnate Biopharma Inc by 73.33%. The purchase prices were between $17.81 and $24.87, with an estimated average price of $21.83. The stock is now traded at around $20.470000. The impact to a portfolio due to this purchase was 0.63%. The holding were 1,847,559 shares as of 2021-09-30.

Boxer Capital, Llc added to a holding in Centessa Pharmaceuticals PLC by 47.55%. The purchase prices were between $16.7 and $23.11, with an estimated average price of $20.76. The stock is now traded at around $11.380000. The impact to a portfolio due to this purchase was 0.25%. The holding were 1,334,227 shares as of 2021-09-30.

Boxer Capital, Llc sold out a holding in Seagen Inc. The sale prices were between $142.45 and $169.82, with an estimated average price of $155.61.

Boxer Capital, Llc sold out a holding in Amarin Corp PLC. The sale prices were between $3.94 and $5.84, with an estimated average price of $4.91.

Boxer Capital, Llc sold out a holding in Therapeutics Acquisition Corp. The sale prices were between $10.27 and $10.27, with an estimated average price of $10.27.

Boxer Capital, Llc sold out a holding in Kadmon Holdings Inc. The sale prices were between $3.55 and $9.09, with an estimated average price of $5.66.

Boxer Capital, Llc sold out a holding in Agenus Inc. The sale prices were between $4.98 and $6.63, with an estimated average price of $5.76.

Boxer Capital, Llc sold out a holding in Biomarin Pharmaceutical Inc. The sale prices were between $74.77 and $85.47, with an estimated average price of $79.09.